Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06902298 · ClinicalTrials.gov registry record · Phase 1
Personalized Ultrasonic Brain Stimulation for Depression (R61)
A Phase 1 study of Depression - Major Depressive Disorder and Major Depressive Episode, sponsored by Brian Mickey.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06902298 is a Phase 1 study of Depression - Major Depressive Disorder and Major Depressive Episode that is actively recruiting participants, run by Brian Mickey. The registered enrollment target is 30 participants, below the 101-participant average among 19 other Depression - Major Depressive Disorder trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06902298, a Phase 1 study of Depression - Major Depressive Disorder and Major Depressive Episode, is actively recruiting participants, sponsored by Brian Mickey.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate a new form of non-invasive brain stimulation for individuals with depression. Personalized low-intensity transcranial focused ultrasound stimulation will be delivered using a range of stimulation parameters during psychological and physiological monitoring. Individualized optimal targets will be selected using structural MRI and diffusion tractography. Brain target engagement will be evaluated using functional MRI.
Conditions Studied
Interventions
- DEVICE LTFUS to SCC
- DEVICE LTFUS to ALIC
Study Locations (1)
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-03-10 |
| Est. Completion | 2026-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06902298
The ClinicalTrials.gov registry entry for NCT06902298 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 101-participant average among 19 other Depression - Major Depressive Disorder trials with a reported enrollment target (70% lower). The listed sponsor is Brian Mickey, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Depression - Major Depressive Disorder appearing as the primary indexed condition, and to 2 interventions - of which LTFUS to SCC is the first listed.
NCT06902298 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT06902298 about?
NCT06902298 is a clinical study titled "Personalized Ultrasonic Brain Stimulation for Depression (R61)". This study will evaluate a new form of non-invasive brain stimulation for individuals with depression. Personalized low-intensity transcranial focused ultrasound stimulation will be delivered using a range of stimulation parameters during psychological and physiological monitoring. Individualized op...
What is the current status of trial NCT06902298?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2025-03-10. Estimated completion is 2026-11.
What conditions does trial NCT06902298 study?
This clinical trial studies the following conditions: Depression - Major Depressive Disorder, Major Depressive Episode, Treatment-Resistant Major Depressive Disorder.
What interventions are being tested in trial NCT06902298?
The interventions under investigation include: LTFUS to SCC (DEVICE), LTFUS to ALIC (DEVICE).
Who is sponsoring clinical trial NCT06902298?
This trial is sponsored by Brian Mickey, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06902298 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression - Major Depressive Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Open-Label Psilocybin Study in Transdiagnostic Population
RECRUITING · Phase 1
-
Modulating Spinal Interoceptive Pathways to Evaluate Their Role and Therapeutic Potential in MDD Symptomatic Domains
RECRUITING · Phase 1
-
Use of a Generative AI (Gen-AI) Chatbot for Anxiety and Depression Among Persons With Cannabis Use
RECRUITING · Phase 1
-
Digital Intervention for Physical Activity
RECRUITING · NA
-
The Effect of PROSE or Scleral Lenses on Mental Health
RECRUITING
-
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
RECRUITING · Phase 3
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.